Gene: TAF11L14
Official Full Name: TATA-box binding protein associated factor 11 like 14provided by HGNC
Gene Summary: Predicted to enable protein heterodimerization activity. Predicted to contribute to RNA polymerase II general transcription initiation factor activity. Predicted to be involved in RNA polymerase II preinitiation complex assembly. Predicted to be located in nucleus. Predicted to be part of transcription factor TFIID complex. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO13595 | TAF11L14 Knockout cell line (HeLa) | Human | TAF11L14 | 1:3~1:6 | Negative | Online Inquiry |
KO13596 | TAF11L14 Knockout cell line (HCT 116) | Human | TAF11L14 | 1:2~1:4 | Negative | Online Inquiry |
KO13597 | TAF11L14 Knockout cell line (A549) | Human | TAF11L14 | 1:3~1:4 | Negative | Online Inquiry |
TAF11L14 Gene Knockout Cell Lines are specifically engineered cellular models that facilitate the study of gene function and regulation in various biological processes. Utilizing CRISPR-Cas9 technology, these cell lines feature a complete knockout of the TAF11L14 gene, which is crucial for various transcriptional activities within the cell. By abolishing this gene, researchers can closely examine the downstream effects on cellular pathways, including those involved in gene expression, replication, and repair mechanisms.
The key function of TAF11L14 is its role as a transcription factor and a member of the TFIID complex, which is paramount for the initiation of transcription by RNA polymerase II. By studying knockout variants, researchers can gain insight into how the absence of TAF11L14 impacts transcriptional regulation, chromatin remodeling, and cellular responses to environmental stimuli, making these cell lines a significant tool in gene regulatory research.
In both research and clinical settings, TAF11L14 Gene Knockout Cell Lines are vital for deciphering the complexities of genetic diseases, cancer biology, and therapeutic interventions. Their application extends to drug discovery, where understanding altered cellular responses can lead to novel treatment strategies tailored for specific genetic backgrounds.
Compared to other gene knockout models, TAF11L14 cell lines stand out due to their precise modification and the robustness of the CRISPR-Cas9 platform. This technology ensures high efficiency and specificity in gene targeting, reducing off-target effects and increasing the reliability of experimental outcomes.
Researchers and clinicians will find immense value in these cell lines as they offer unprecedented access to the functional analysis of the TAF11L14 gene, paving the way for advancements in medical research and potential therapeutic developments. Our company specializes in providing scientifically validated biological tools, ensuring that our products meet the highest standards of quality and performance, ultimately supporting the scientific community's quest for knowledge and innovation.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.